Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer

Conclusions: These findings suggest that TLR4 is expressed in a functional form in ER/PR-negative breast cancers. Studies regarding TLR4-antagonist therapies should be focusing on ER/PR-negative breast cancer particularly.

http://breast-cancer-research.com/content/17/1/130

Source: Breast Cancer Research - September 22, 2015 Category: Cancer & Oncology Authors: Meliha MehmetiRoni AllaouiCaroline BergenfelzLao SaalStephen EthierMartin JohanssonKarin JirströmKarin Leandersson Source Type: research